Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17323453 | 0.91 | ALDH1A1 (0.41) | ALDH1A1SOAT1 | |
| SCHEMBL17323460 | 0.91 | ALDH1A1 (0.41) | ALDH1A1SOAT1 | |
| SCHEMBL17481739 | 0.89 | ALDH1A1 (0.39) | ALDH1A1SOAT1 | |
| SCHEMBL807499 | 0.89 | — | — | |
| SCHEMBL807505 | 0.88 | — | — | |
| SCHEMBL17263569 | 0.87 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10LMNAGAA | |
| SCHEMBL10249500 | 0.87 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10LMNAGAA | |
| SCHEMBL12994060 | 0.87 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL7055423 | 0.87 | — | — | |
| SCHEMBL11986242 | 0.87 | ALDH1A1 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024191025-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS | 한국콜마주식회사 | 2024-09-19 | — | — | WO | claimed |
| WO-2024046605-A1 | COMPOUNDS FOR THE DETECTION OF LIGANDROL | NATIONAL CENTER FOR SCIENTIFIC RESEARCH "DEMOKRITOS" (GR) | 2024-03-07 | — | — | WO | claimed |
| US-10570088-B2 | Blood brain barrier-penetrating oximes for cholinesterase reactivation | HUMAN BIOMOLECULAR RES FOUNDATION (US) | 2020-02-25 | — | — | US | claimed |
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2018-05-10 | — | — | US | claimed |
| US-20170349538-A1 | Blood Brain Barrier-Penetrating Oximes for Cholinesterase Reactivation | Human BioMolecular Research Foundation (US) | 2017-12-07 | — | — | US | claimed |
| WO-2016151508-A1 | METHOD AND APPARATUS FOR THE PRODUCTION OF DIARYL CARBONATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-09-29 | — | — | WO | claimed |
| EP-2727915-B1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | CONCERT PHARMACEUTICALS INC (US) | 2016-04-13 | — | — | EP | claimed |
| EP-2727915-A1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | Concert Pharmaceuticals Inc. (US) | 2014-05-07 | — | — | EP | claimed |
| US-20140051712-A1 | BLOOD BRAIN BARRIER-PENETRATING OXIMES FOR CHOLISTENERASES REACTIVATION | HUMAN BIOMOLECULAR RESEARCH INSTITUTE | 2014-02-20 | — | — | US | claimed |
| WO-2012083261-A1 | BLOOD BRAIN BARRIER-PENETRATING OXIMES FOR CHOLISTENERASES REACTIVATION | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2012-06-21 | — | — | WO | claimed |
| EP-1979362-B1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2010-12-15 | — | — | EP | claimed |
| US-20090005269-A1 | Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-01-01 | — | — | US | claimed |
| CN-122094698-A | Ligands for extrahepatic delivery of siRNA | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4419513-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2025-08-27 | — | — | EP | disclosed |
| EP-4604951-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | AMIRA THERAPEUTICS, S.L. (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-12384800-B2 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2025-08-12 | — | — | US | disclosed |
| EP-0779312-A2 | Manufacturing method for polycarbonate | GENERAL ELECTRIC COMPANY (US) | 1997-06-18 | — | — | EP | disclosed |
| EP-0461274-B1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | ASAHI CHEMICAL IND (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5210268-A | Ester interchange, catalysis | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0461274-A1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12384800-B2 | Antitumoral compounds | TP53, TOP1, MCL1 | ALDH1A1 144/4885SOAT1 3269/4885TSHR 4670/4885 |
| US-20090005269-A1 | Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | SELE, ELANE, EPCAM | ALDH1A1 374/4885SOAT1 2122/4885TSHR 3246/4885 |
| US-10570088-B2 | Blood brain barrier-penetrating oximes for cholinesterase reactivation | ACHE, BCHE, PYGB | ALDH1A1 1236/4885SOAT1 896/4885TSHR 2012/4885 |
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, NOS3 | ALDH1A1 303/4885SOAT1 3454/4885TSHR 2059/4885 |
| US-20140051712-A1 | BLOOD BRAIN BARRIER-PENETRATING OXIMES FOR CHOLISTENERASES REACTIVATION | BCHE, ACHE, PYGB | ALDH1A1 1908/4885SOAT1 279/4885TSHR 2320/4885 |
| US-20170349538-A1 | Blood Brain Barrier-Penetrating Oximes for Cholinesterase Reactivation | ACHE, BCHE, PYGB | ALDH1A1 1236/4885SOAT1 896/4885TSHR 2012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.